Clinical Case Summary
Introduction: Granulomatous appendicitis is a rare condition and may occasionally represent the first manifestation of systemic diseases such as Crohn’s disease. Isolated appendiceal involvement is uncommon and can present atypically, complicating diagnosis. We report an unusual presentation of Crohn’s disease as a painless abdominal mass secondary to chronic appendiceal inflammation.
Clinical case: A 26‑year‑old non‑smoking man presented with a one‑month history of a progressively enlarging, painless palpable mass in the right iliac fossa, measuring 3–4 cm. He denied abdominal pain, bowel habit changes, rectal bleeding, or weight loss. His only relevant history was a perianal abscess with a superficial transsphincteric fistula surgically treated two months earlier, with good evolution and no recurrence.
Abdominal CT showed an enlarged appendix (12 mm) with inflammatory changes in the adjacent mesenteric fat. Ileocolonoscopy revealed no macroscopic abnormalities, although caecal biopsies showed chronic lymphoplasmacytic inflammation. A planned appendicectomy was performed.
Histopathology confirmed granulomatous appendicitis. The patient remained asymptomatic during follow‑up. Capsule endoscopy revealed multiple aphthous ulcers from the distal duodenum to the terminal ileum. Faecal calprotectin was normal. Pelvic MRI demonstrated a small transsphincteric fistula without external opening. Based on these findings, a diagnosis of Crohn’s disease was established.
Conclusion: This case is exceptional due to its presentation as a painless abdominal mass and the absence of initial gastrointestinal symptoms. It highlights the importance of gastroenterological evaluation after appendicectomy when histological findings suggest Crohn’s disease. Capsule endoscopy may be useful for detecting small‑bowel involvement not identified by other techniques.
References
1. Mostyka M, Fulmer CG, Hissong EM, Yantiss RK. Crohn Disease InfrequentlyAffects the Appendix and Rarely Causes Granulomatous Appendicitis. American Journal of Surgical Pathology. 2021;45(12):1703-1706. doi:10.1097/PAS.0000000000001734,
2. Han H, Kim H, Rehman A, Jang SM, Paik SS. Appendiceal Crohn’s diseaseclinically presenting as acute appendicitis. World J Clin Cases. 2014;2(12):888. doi:10.12998/WJCC.V2.I12.888
3. Cerdán FJ, Balsa T, Torres-Melero J, García MC, Remezal M, Balibrea JL. Enfermedad de Crohn apendicular [Appendiceal Crohn’s disease]. Rev Esp Enferm Dig. 1995;87(4):331-334.
4. Bronner MP. Granulomatous appendicitis and the appendix in idiopathicinflammatory bowel disease. Semin Diagn Pathol. 2004;21(2):98-107. doi:10.1053/j.semdp.2004.12.001
5. Prieto-Nieto I, Perez-Robledo JP, Hardisson D, Rodriguez-Montes JA, Larrauri-Martinez J, Garcia-Sancho-Martin L. Crohn’s disease limited to the appendix. Am J Surg. 2001;182(5):531-533. doi:10.1016/S0002-9610(01)00811-X
Disclosure
OML has received educational funding from Takeda, Abbvie, Johnson&Johnson, Kern Pharma, Alfasigma, Pfizer, Lilly, Sandoz, Dr. Falk Pharma, Ferring, and Tillotts, and has also served as a speaker for Takeda, Abbvie, Alfasigma, and Lilly.
EMZ has nothing to disclosure.
MAT has received educational funding from Takeda, Abbvie, Johnson&Johnson, Kern Pharma, Alfasigma, Pfizer, Lilly, Sandoz, Dr. Falk Pharma, Ferring, and Tillotts, and has also served as a speaker for Abbvie.
MJCR has received educational funding from Takeda, Abbvie, Johnson&Johnson, Kern Pharma, Alfasigma, Pfizer, Lilly, Sandoz, Dr. Falk Pharma, Ferring, and Tillotts, and has also served as a speaker for Abbvie and Alfasigma.
GGGA has received educational funding from Takeda, Abbvie, Johnson&Johnson, Kern Pharma, Alfasigma, Pfizer, Lilly, Sandoz, Dr. Falk Pharma, Ferring, and Tillottsa, and has also served as a speaker for Takeda and Tillots.
LRD has received educational funding from Takeda, Abbvie, Johnson&Johnson, Kern Pharma, Alfasigma, Pfizer, Lilly, Sandoz, Dr. Falk Pharma, Ferring, and Tillotts, and has also served as a speaker for Takeda.
RAGR has nothing to declare.